King Pharmaceuticals, Inc. Mergers and Acquisitions


King Pharmaceuticals, Inc.

501 Fifth Street
Bristol, TN 37620
United States
Tel:1/423/989-8000
URL: http://www.kingpharm.com
Primary Symbol & Exchange:
KG - Common Stock - New York Stock Exchange
Industry:
Pharmaceutical
King Pharmaceuticals, Inc. Company Snapshot

King Pharmaceuticals, Inc. Deal Timeline


Drag the timeline to see more deals; click on a deal to see details.


Acquisitions > 100 M$ 10 to 100 M$ < 10M$ Stakes Divestitures

King Pharmaceuticals, Inc. M&A History


Actavis Elizabeth LLC acquires King Pharm-Kadian Prod Line from King Pharmaceuticals Inc Actavis Elizabeth LLC acquires King Pharm-Kadian Prod Line from King Pharmaceuticals IncDec 30, 2008

US - Actavis Elizabeth LLC, a unit of Actavis Group HF, acquired the Kadian product line of King Pharmaceuticals Inc, a pharmaceuticals manufacturer, for up to an estimated $###.# mil in profit-related payments. Concurrently, KP acquired all the outstanding

King Pharmaceuticals Inc launches a tender offer for Alpharma Inc King Pharmaceuticals Inc launches a tender offer for Alpharma IncDec 30, 2008

US - King Pharmaceuticals Inc (KP) acquired all the outstanding common stock of Alpharma Inc, a manufacturer of pharmaceuticals, via a tender offer for a sweetened $## in cash per share, or a total value of $#.### bil. The transaction

JHP Pharmaceuticals LLC acquires King Pharm Inc-Mnfg Facility from King Pharmaceuticals Inc JHP Pharmaceuticals LLC acquires King Pharm Inc-Mnfg Facility from King Pharmaceuticals IncOct 02, 2007

US - JHP Pharmaceuticals LLC acquired the sterile manufacturing facility, located in Rochester, Michigan, of King Pharmaceuticals Inc, a manufacturer and wholesaler of pharmaceuticals, for an estimated $## mil. The transaction had been subject to regulatory approval. The transaction included the

King Pharmaceuticals Inc acquires Ligand Pharmaceuticals Inc- from Ligand Pharmaceuticals Inc King Pharmaceuticals Inc acquires Ligand Pharmaceuticals Inc- from Ligand Pharmaceuticals IncFeb 26, 2007

US - King Pharmaceuticals Inc acquired the AVINZA product line of Ligand Pharmaceuticals Inc, a manufacturer of pharmaceuticals, for $### mil. The consideration consisted of $### mil and the assumption of $## mil in liabilities. The transaction had been subject to

Duramed Pharmaceuticals Inc acquires King Pharm-Nordette Rights from King Pharmaceuticals Inc Duramed Pharmaceuticals Inc acquires King Pharm-Nordette Rights from King Pharmaceuticals IncDec 28, 2004

US - Duramed Pharmaceuticals Inc, a unit of Barr Pharmaceuticals Inc, acquired the Nordette rights from King Pharmaceuticals Inc, a manufacturer and wholesaler of branded and generic prescription products, for an estimated $## mil. The transaction included the exlusive rights to

Barr Pharmaceuticals Inc acquires King Pharmaceuticals-Prefest from King Pharmaceuticals Inc Barr Pharmaceuticals Inc acquires King Pharmaceuticals-Prefest from King Pharmaceuticals IncNov 22, 2004

US - Barr Pharmaceuticals Inc acquired the rights to Prefest from King Pharmaceuticals Inc, a manufacturer and wholesaler of pharmaceutical, products, for $## mil.

Mylan Laboratories Inc withdraws offer for King Pharmaceuticals Inc Mylan Laboratories Inc withdraws offer for King Pharmaceuticals IncJul 26, 2004

US - Mylan Laboratories Inc (MLI) withrew its definitive agreement to acquire all the outstanding common stock of King Pharmaceuticals Inc (KP), a manufacturer and wholesaler of pharmaceuticals, in a stock swap transaction valued at $#.### bil. MLI offered .#

Novavax Inc acquires King Pharm-ESTRASORB(R) from King Pharmaceuticals Inc Novavax Inc acquires King Pharm-ESTRASORB(R) from King Pharmaceuticals IncJul 19, 2004

US - Novavax Inc (NI) reacquired all the rights to ESTRASORB (R) and certain women's health products of King Pharmaceuticals Inc (KP), manufacturer of pharmaceuticals for $##.### mil. The consideration consisted of $## mil in cash and #.###

Salix Pharmaceuticals Ltd acquires King-Anusol-HC(R) & Cert Prod from King Pharmaceuticals Inc Salix Pharmaceuticals Ltd acquires King-Anusol-HC(R) & Cert Prod from King Pharmaceuticals IncJul 01, 2004

US - Salix Pharmaceuticals Ltd acquired the Anusol-HC(R) rights and certain products of King Pharmaceuticals, a manufacturer and wholesaler of pharmaceutical products, for $## mil in cash.

Virbac Corp acquires King Phar-Animal Health Prod from King Pharmaceuticals Inc Virbac Corp acquires King Phar-Animal Health Prod from King Pharmaceuticals IncSep 09, 2003

US - Virbac Corp acquired the animal health products asset of King Pharmaceuticals Inc, a manufacturer and wholesaler of pharmaceutical products, for $##.# mil in cash.

King Pharmaceuticals Inc acquires Elan Corp PLC-Primary Care from Elan Corp PLC King Pharmaceuticals Inc acquires Elan Corp PLC-Primary Care from Elan Corp PLCJun 13, 2003

US - King Pharmaceuticals Inc (KP) acquired the primary care business of Elan Corp PLC (EL), a manufacturer of neurological therapies, located in the United States and Puerto Rico, for an amended $### mil, including the assumption of an estimated $###

King Pharmaceuticals Inc launches a tender offer for Meridian Medical Technologies King Pharmaceuticals Inc launches a tender offer for Meridian Medical TechnologiesJan 08, 2003

US - King Pharmaceuticals Inc acquired all the outstanding common stock of Meridian Medical Technologies Inc, a manufacturer of syringes and injectors, for $##.# in cash per share, or a total value of $###.### mil. The boards of both

King Pharmaceuticals Inc acquires Aventis-Intale,Tilade,Sunercid from Sanofi-Aventis SA King Pharmaceuticals Inc acquires Aventis-Intale,Tilade,Sunercid from Sanofi-Aventis SADec 31, 2002

FRANCE - King Pharmaceuticals Inc acquired the Intale, Tilade and Sunercid products rights of Aventis SA, a manufacturer of pharmaceuticals, for ###.## mil Euros ($###.# mil US). The consideration consisted of ###.### mil Euros in cash ($###.#

King Pharmaceuticals Inc acquires Ortho-McNeil Pharmaceutical from Johnson & Johnson Inc King Pharmaceuticals Inc acquires Ortho-McNeil Pharmaceutical from Johnson & Johnson IncMay 29, 2002

US - King Pharmaceuticals Inc definitively acquired the Ortho-Prefest tablet brand of Johnson & Johnson's Ortho-McNeil Pharmaceutical Corp subsidiary, a manufacturer of pharmaceuticals, for $### mil, including $# mil which was to be contingent upon the FDA's approval

King Pharmaceuticals Inc acquires Bristol-Myers Squibb-US Rights from Bristol-Myers Squibb Co King Pharmaceuticals Inc acquires Bristol-Myers Squibb-US Rights from Bristol-Myers Squibb CoAug 09, 2001

US - King Pharmaceuticals Inc acquired the US rights to # pharmaceuticals from Bristol-Myers Squibb Co, a manufacturer of drugs and cosmetics, for $### mil. The transaction was to include the rights to Corzide, a receptor blocker and diuretic; Delestrogen

Novavax Inc acquires King Pharmaceuticals Inc-AVC from King Pharmaceuticals Inc (pending) Novavax Inc acquires King Pharmaceuticals Inc-AVC from King Pharmaceuticals Inc (pending)Jan 09, 2001

US - Novavax Inc agreed to acquire the AVC brand of creams from King Pharmaceutical Inc, a manufacturer of pharmaceutical products, for $#.# mil.

King Pharmaceuticals Inc acquires Jones Pharmaceutical Inc King Pharmaceuticals Inc acquires Jones Pharmaceutical IncAug 31, 2000

US - King Pharmaceuticals Inc(KP) acquired all the outstanding common stock of Jones Pharmaceutical Inc(JP), a manufacturer of drug products and vitamins, in a stock swap transaction valued at $#.### bil. KP offered #.### shares per JP

American Home Products Corp acquires a minority stake in King Pharmaceuticals Inc (pending) American Home Products Corp acquires a minority stake in King Pharmaceuticals Inc (pending)Jun 23, 2000

US - American Home Products Corp (AHP) planned to acquire an undisclosed minority stake in King Pharmaceuticals Inc (KP), a manufacturer of pharmaceutical products, for $## mil. AHP and KP were to co-promote King's cardiovascular and hypertension drug Altace.

King Pharmaceuticals Inc acquires Medco Research Inc King Pharmaceuticals Inc acquires Medco Research IncFeb 25, 2000

King Pharmaceuticals Inc (KP) acquired all the outstanding common stock of Medco Research Inc (MR) in a stock swap transaction valued at $###.## mil. KP offered $## in common stock per MR share. Originally KP offered .#### common shares

King Pharmaceuticals Inc acquires Hoechst Marion Roussel-Prods from Sanofi-Aventis SA King Pharmaceuticals Inc acquires Hoechst Marion Roussel-Prods from Sanofi-Aventis SADec 22, 1998

King Pharmaceuticals acquired # branded prescription pharmaceutical products from Hoechst Marion Roussel, a unit of Hoechst, for ###.### mil Deutsche marks ($###.# mil US). The products were Altace, AVC, and Silvadene.

King Pharmaceuticals, Inc. M&A Summary


King Pharmaceuticals, Inc. has made 15 acquisitions while taking stakes in 0 companies. King Pharmaceuticals, Inc. has 9 divestitures during this period.
YearAcquisitionsStakesDivestitures
2009000
2008101
2007101
2006000
2005000
2004004
2003201
2002200
2001100
2000200
1999000
1998401
1997100
1996100
1995000
1994000
1993000
1992000
1991000
1990000
1989001
Total1509

Other Recent M&A in the Pharmaceutical industry